Ingredient

Rivastigmine Tartarate

Rivastigmine tartrate is a central nervous system drug component used to improve the symptoms of Alzheimer's type dementia.

See medicines used for Mental & Nervous System
All medicines
85
Single ingredient
85
Prescription medication
85

MFDS ingredient code M252069

What does it do?

Rivastigmine tartrate is a medication that acts on the central nervous system and is used to improve cognitive function in patients with Alzheimer's type dementia. This component belongs to the class of cholinesterase inhibitors and helps facilitate nerve signal transmission by slowing the breakdown of the neurotransmitter acetylcholine in the brain.

Rivastigmine tartrate inhibits the enzyme cholinesterase, which breaks down acetylcholine in the brain. As a result, the concentration of acetylcholine increases, facilitating signal transmission between nerve cells, thereby improving memory and cognitive function.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other cholinesterase inhibitors, rivastigmine has relatively fewer side effects and inhibits dopamine-degrading enzymes to some extent, making it usable for patients with Parkinson's disease. Additionally, it has a shorter duration of action compared to other components, making dosage adjustment easier.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

85 total

View more

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.